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Background: The role of myeloperoxidase (MPO) is essential in the killing of phagocytosed bacteria. Certain steroid
hormones increase MPO plasma concentration. Our aim was to test the effect of MPO, its inhibitor indomethacin,
and certain steroid hormones on bactericidal activity.
Methods: Human polymorphonuclear leukocytes (PMN) were incubated with opsonised Escherichia coli and either
MPO, indomethacin, estradiol, or hydrocortisone. Intracellular killing capacity was evaluated with UV microscopy
after treatment with fluorescent dye. Next, an in vivo experiment was performed with nine groups of rats: in the
first phase of the study indomethacin treatment and Pasteurella multocida infection (Ii), indomethacin treatment
without infection (I0), untreated control with infection (Mi) and untreated control without infection (M0); in the
second phase of the study rats with infection and testosterone treatment (NT), castration, infection and testosterone
treatment (CT), castration, infection and estradiol treatment (CE), non-castrated infected control (N0), and castrated
infected control (C0). After treatment bacteria were reisolated from the liver and heart blood on agar plates, and
laboratory parameters were analyzed. For the comparison of laboratory results ANOVA or Kruskal-Wallis test and
LSD post hoc test was used.
Results: Indomethacin did not have a remarkable effect on the bacterial killing of PMNs, while the other compounds
increased bacterial killing to various degrees. In the animal model indomethacin and infection caused a poor clinical
state, a great number of reisolated bacteria, elevated white blood cell (WBC) count, decreased C-reactive protein (CRP)
and serum albumin levels. Testosterone treatment resulted in less bacterial colony numbers in group NT, but not in
group CT compared to respective controls (N0, C0). Estradiol treatment (CE) decreased colony numbers compared to
control (C0). Hormone administration resulted in lower WBC counts, and in group CE, a decreased CRP.
Conclusions: MPO, estradiol, and hydrocortisone improve bacterial killing activity of PMNs. Indomethacin treatment
and castration weaken immune responses and clinical state of infected rats, while testosterone and estradiol have a
beneficial effect.
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Free radicals are very reactive compounds with one or
more unpaired electrons on their outer orbitals. They
are of great importance in the bacterial killing role of mac-
rophages. The most important reactive oxygen radical is
the superoxide anion with limited reactivity, but it can be
converted into other more reactive radicals. Its main
source is NADPH, which is oxidased by NADPH oxidase
(NOX). Superoxide anion can be converted into hydrogen
peroxide (H2O2) by superoxide dismutase (SOD), and the
produced H2O2 is used in the oxidation of chloride ions to
hypochlorous acid (HOCl) with the catalyzation of myelo-
peroxidase (MPO). HOCl deploys bactericidal activity on
the bacteria ingested in the phagosome. Additionally, chlo-
ramines generated by HOCl reacting with phagosomal
proteins also contribute to bacterial killing, but the full
consequences of this are not yet clear [1,2].
However, under certain circumstances an excess of
these oxidizing species can overwhelm local antioxidant
defence and lead to oxidative stress (OS) and tissue in-
jury that are implicated in the pathogenesis of diseases
like atherosclerosis, emphysema, acute respiratory dis-
tress syndrome, reperfusion injury, malignancy, diabetes
mellitus, and Alzheimer’s disease [2].
The tissues are protected against free radicals by anti-
oxidant enzymes (such as SOD, catalase, glutathione
reductase, α1-antitripsin), peptides with thiol groups
(glutathione, thioredoxin family) and nutritional anti-
oxidants (vitamin C and E, carotenoids, trace elements)
[2,3]. Certain steroid hormones also play a role in antioxi-
dant defence through various mechanisms. In our previ-
ous work we demonstrated that cortisol, 17-ß-oestradiol
(E2), progesterone, and testosterone decreased the super-
oxide release from human PMNs, while aldosterone and
cortexolone, the precursor of cortisol did not have such
property [4].
In the literature the most extensively studied steroid
hormone is E2. It enhances the cellular anti-oxidative de-
fence molecules, reduces the production of reactive oxy-
gen species (ROS), activates endothelial, inducible and
neuronal nitric oxide synthase, and neutralizes the ex-
cess ROS in various cell types [5].
The mechanism of antioxidant action of hydrocorti-
sone is scantly studied in the literature. It is mainly re-
ferred to as the main biomarker of stress, which leads to
oxidative changes [6]. However, a correlation between
plasma hydrocortisone and Cu/Zn SOD activity has been
recorded in rhesus monkeys, and both have been found to
have a similar diurnal rhythm [7]. Other glucocorticoids
have both glucocorticoid receptor mediated genomic and a
rapid non-genomic antioxidant effect [8,9].
The antioxidant effect of testosterone is ambiguous in
the literature. In one study it showed a receptor-
mediated antioxidant effect in vitro on cerebellar granulecells [10], but according to others it caused a decrease in
the activity of antioxidant enzymes and led to lipid peroxi-
dation in the prostate and testis of rodents [11,12].
MPO has also been reported to have antioxidant cap-
acity despite its known free radical producing activity. It
contributes to the termination of free radical production
in PMNs [13,14], and the incubation of human PMNs
with MPO and NaClO, the end-product of the MPO cat-
alyzed peroxidation, yielded a decrease in superoxide re-
lease, probably by inhibiting NOX [14,15]. In fact, it has
been found, that MPO release and activity in PMNs can
be enhanced by certain steroids, like E2, testosterone,
and prednisolone. Thus, the antioxidant effect of these
steroid hormones might be carried out at least in part by
the elevation of MPO activity and release [14-16]. On
the other hand, the MPO inhibitor indomethacin, a non-
steroidal anti-inflammatory drug, a nonselective cycloox-
ygenase inhibitor increases free radical production in
PMNs [14,17]. This could mean a beneficial effect in the
bactericidal activity of PMNs.
In our present studies we aimed to evaluate the effect
of indomethacin on ex vivo and in vivo bactericidal func-
tion. We also tested MPO, E2, and hydrocortisone on
antibacterial capability of human PMNs, and the effect
of indomethacin, testosterone, and E2 on an in vivo rat
model. Our ultimate aim was to evaluate if indometh-
acin can be useful as an adjuvant therapy in septic pa-
tients. Since the two experimental models are different,
and sex steroids have various effects on many participants
of the immune system besides PMNs, the comparison of
the results of the two experiments needs caution.
Methods
Ex vivo effect of indomethacin, MPO, estradiol, and
hydrocortisone on the bactericidal activity of human
isolated PMNs
Isolation of PMNs
Venous blood was drawn from 6 male and 5 female do-
nors, aged 23–40 years. All volunteers were non-smokers,
took no medications, did not suffer from any known dis-
ease and consented to participation. The blood was taken
into EDTA tubes between 8–9 a.m. after an overnight fast-
ing. PMNs were separated within 2 hours of blood drawing
with the following method. The blood was applied to
Histopaque (Sigma, 1077–1) in layers for the sedimenta-
tion of red blood cells and put aside for an hour. Then it
was transferred to 63% and 72% Percoll (Sigma, P-1644)
and centrifuged for 25 min at a rate of 300 × g at 20°C.
Granulocytes thus separated were buffer-washed twice and
centrifuged with 220 × g. Cells aggregated at the bottom of
the tube were re-suspended in a few milliliters of Hank’s
buffer salt solution (Sigma, H-8264), then counted using
Turk’s solution. The cell concentration of the suspension
was adjusted to 5 million cells/ml.
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Escherichia coli O111:K58 strain was used. The bacterial
strain was cultivated on blood agar plates overnight at
37°C. A loopful of bacteria was suspended in 200 μl of
Hank’s buffer. After adding 4 drops of antibody to the
suspension it was incubated for 30 min at 37°C. The
antibody was specifically produced for E. coli O111:K58
strain by the National Centre of Epidemiology, Budapest,
Hungary.
Intracellular bacterial killing
400 μl (2×106) of 5×106/ml PMNs were incubated for
2 hours at 37°C in a water bath either with 0.01 mg/ml
indomethacin (Sigma, I7378-5G), 71 ng/ml MPO (Merck,
475911), 10−8 mol 17ß-oestradiol (Sigma, E8875) or
10−8 mol hydrocortisone (Sigma, H4001). Control cells
were incubated without any treatment. After incubation,
PMNs were mixed with 2×107 opsonised E. coli cells, and
the compounds were kept in the water bath for further
30 min. After this, 1–1 ml of ice-cold Hank’s buffer was
added to each compound, and they were centrifuged for
7 min at 6000 rpms. After having removed the aliquots,
the pellets were dyed with 200 μl (1.44 ml/100 ml Hank’s
buffer) acridine orange (Sigma, A6014-10G) for one mi-
nute. Then again 1 ml cold Hank’s buffer was added and
the mixtures were centrifuged for 5 min at 10,000 rpms.
The aliquots were removed and bacterial killing was ex-
amined in the pellets. Acridine orange stains only dead
bacteria, which fluoresce in orange when excited by
ultraviolet light. The bacterial killing effect was evaluated
visually under UV microscope (Leica, DMRB DIC). Sev-
eral fields of vision were examined for each sample in
order to find the true amount of dead bacteria. To ex-
press intracellular killing effect of the various drugs a
scoring system from 0–5 was set up, where 0 indicates
no bacterial killing and 5 indicates a hypothetical max-
imal killing. The results of bacterial killing were also
expressed as percentages compared to the control, which
is considered 100%. From the results of parallel measure-
ments an average was calculated.
Effect of indomethacin, testosterone, and estradiol on the
bactericidal activity in vivo in rats
The in vivo experiments were carried out in two phases.
SPF adult male Wistar rats {Crl.(Wi)Br.} weighing 120–
170 grams were used for both experiments. In the first
phase animals were kept in groups of eight, had access
to conventional rat food (Ssniff R-Z, Spezialdiaten
GmbH, Soest, Germany) and fresh drinking water ad
libitum. The rats were given the following treatments
through a feeding tube for five days, once daily: groups M0
and Mi: 0.8 ml of 1% methylcellulose solution; groups I0
and Ii: 0.8 mg indomethacin [0.8 ml of 1 mg/ml indometh-
acin (Sigma, 865500-5G) dissolved in 1% methylcellulose].In the names of the groups, the uppercase letter refers to
the treatment (M=methylcellulose, I = indomethacin), “0”
means no infection and “i” refers to infection.
On the 3rd day of treatment rats in groups Mi and Ii
were infected with Pasteurella multocida ssp. septica. Prior
to infection, Pasteurella multocida ssp. septica (isolate
P964) was stored in 1 ml of skimmed milk at −70°C. The
isolate was streaked onto Columbia agar plate (Merck,
Darmstadt, Germany) containing 5% (v/v) defibrinated
sheep's blood and cultivated at 37°C for 24 hours. Single
colonies were passed and cultivated again at 37°C for
24 hours. Bacterium culture was washed with 2 ml saline.
Rats were infected with a subcutaneous injection of 0.2 ml
of 6×108 colony forming units (CFU)/ml bacteria diluted
in physiological saline (1.2×108 germs/animal). Uninfected
animals got 0.2 ml saline on the same route.
On the 5th day of treatment animals were anaesthe-
tized with diethyl ether and exsanguinated through the
abdominal aorta. Blood was collected for laboratory ana-
lysis of inflammatory markers and hormone levels. Blood
count, serum proteins, CRP, serum testosterone and es-
tradiol were determined with well established automated
laboratory methods used in clinical practice at the Szent
Istvan University, Faculty of Veterinary Science, Depart-
ment and Clinic of Internal Medicine, Budapest.
Isolation of the infective agent was attempted from
each liver and heart blood. A loopful of sample was
streaked onto Columbia blood agar (CBA) and plates
were incubated at 37°C for 24 hours. The number of CFUs
was evaluated and isolates were classified as “none”, “1-10
colonies”, “dense, but separate” and “confluent” colony pat-
terns according to the density of the culture. The unin-
fected groups were negative for culturing while the
majority of infected animals gave positive result with vari-
able density. Microbiological examinations were carried
out at the Institute for Veterinary Medical Research of the
Hungarian Academy of Sciences, Budapest.
In the second in vivo phase 30 rats were used and all
of the animals were infected and the effects of hormone
treatments were examined. Animals were kept as de-
scribed previously. Five groups of 6 were created, and 18
rats were castrated. After a 10-day recovery period the
following treatments were given for seven days, twice
daily (8:30 a.m., 6 p.m.) in a subcutaneous injection:
group N0: 0.35 ml propylene glycol, not castrated; group
NT: 0.35 ml of 800 μg/ml testosterone dissolved in pro-
pylene glycol, not castrated; group C0: 0.35 ml propylene
glycol, castrated; group CT: 0.35 ml of 800 μg/ml testos-
terone dissolved in propylene glycol, castrated; group
CE: 0.35 ml of 20 μg/ml 17-ß-estradiol dissolved in
propylene glycol, castrated. In the names of the groups
“N” and “C” mean not castrated and castrated, respect-
ively; “0”, “T” and “E” refer to no treatment, testosterone
and estradiol treatment, respectively.
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with a subcutaneous injection of 0.2 ml of 2.4×109 CFU/ml
Pasteurella multocida ssp. septica diluted in physiological
saline, as described above (4.8×108 germs/animal). On the
7th day of treatment animals were anaesthetized and ex-
sanguinated, laboratory and microbiological examinations
were carried out as in the previous experiment.
Both experiments were approved by the university eth-
ical committee.
Statistical analysis
The Statistica software was used for all analyses. For the
comparison of laboratory results of rats ANOVA or
Kruskal-Wallis test and LSD post hoc test was used.
P < 0.05 was considered statistically significant.
Results
Ex vivo effect of indomethacin, MPO, estradiol, and
hydrocortisone on the bactericidal activity of human
isolated PMNs
The ex vivo effect of indomethacin, MPO, estradiol and
hydrocortisone on bacterial killing are shown in Figure 1.
Due to technical problems not all experiments gave valu-
able results, thus the number of donors (n) is variable
among treatment groups. Indomethacin did not have a re-
markable effect in either direction, using either scale. The
three other compounds seem to increase bacterial killing
of PMNs to various degrees: estradiol is the most efficient,
while hydrocortisone has the least activity.
Effect of indomethacin, testosterone, and estradiol on the
bactericidal activity in vivo in rats
In the first phase of our in vivo studies 1–1 rats were
wasted in the infected groups (Mi, Ii), and 2 in the unin-
fected group treated with indomethacin (group I0) on
the 4th day of treatment, i.e. the day after the infection.
Animals in groups I0 and Ii (treated with indomethacin,Figure 1 The bactericidal activity of PMNs after indomethacin, myelo
Results are expressed as percentage of control (mean ± SD) and as scores (
the diagram. The error bars show standard deviation.without and with infection) were weak and faint. Ascites
was found in two rats in group I0 and one in group Ii.
After the reisolation of P. multocida from liver and car-
diac blood of infected animals, colony patterns were
evaluated (Table 1, Figure 2). The greatest number of
bacteria could be reisolated from the animals in group
Ii, with confluent colonies in 11 samples, vs 3 samples in
group Mi. In group Ii none of the samples gave a nega-
tive reisolation, however, in three samples in group Mi no
colonies were reisolated. The laboratory findings (Table 1)
showed that WBC count was significantly higher in group
Ii than in groups I0 and Mi, with higher neutrophil and
lower lymphocyte ratios in both indomethacin-treated
groups (I0, Ii). In both groups I0 and Ii anaemia was found,
with lower red blood cell (RBC), haemoglobin (HGB) and
haematocrit (HCT) levels compared to the other groups.
Albumin levels were also lower in groups I0 and Ii. CRP
was increased in group Mi compared to uninfected groups,
however, in group Ii CRP decreased. Laboratory analysis
could not be carried out in some samples (2 in group M0,
1 in group I0, 1 in group Mi) due to clotting or insufficient
amount of blood.
In the second phase of the in vivo experiments, during
the 10 days of recovery after castration, weight gain of
castrated animals was less than that of the not castrated
ones, otherwise they were recovering fine. One animal
in group C0 was wasted before the infection without any
clinical antecedent. The section did not reveal any cause,
and liver, heart blood and lung tissue cultures gave nega-
tive results. After the induction of infection all animals
were depressed and faint, especially in group C0. The re-
sults of the reisolation of P. multocida are shown in
Table 2 and Figure 3a-b. In group NT fewer bacteria
could be cultured compared to the untreated (N0)
group. In group CT more bacteria were reisolated than
in group NT and C0. Group CE had similar results as
group NT.peroxidase (MPO), estradiol, and hydrocortisone treatment.
mean ± SD). For better visibility the scores were multiplied by 10 on
Table 1 Results of the first phase of the animal study
1. M0 2. I0 3. Mi 4. Ii p < 0.05
Treatment None (methylcellulose) Indomethacin None (methylcellulose) Indomethacin
Infection No No Yes Yes
Colony patterns: Heart blood Liver Heart blood Liver
None 2 1 0 0
1-10 colonies 3 2 2 1
Dense, but separate 1 4 1 1
Confluent 2 1 5 6
Sample number for lab tests 6 5 6 7
WBC (×109/l) 7.72 ± 2.06 5.09 ± 3.53 5.95 ± 2.61 9.28 ± 1.87 4 vs 2,3
Neutrophil (%) 18.00 ± 4.53 47.40 ± 26.10 22.83 ± 5.64 30.83 ± 9.30 ns
Lymphocyte (%) 80.00 ± 4.36 49.00 ± 28.10 73.67 ± 6.47 64.50 ± 9.22 ns
RBC (×1012/l) 5.94 ± 0.68 3.86 ± 1.52 5.66 ± 0.39 3.66 ± 1.09 4 vs 1
HGB (g/dl) 110.00 ± 9.00 73.40 ± 29.20 105.67 ± 6.83 68.50 ± 18.22 4 vs 1
HCT (l/l) 0.39 ± 0.03 0.26 ± 0.11 0.38 ± 0.03 0.25 ± 0.07 4 vs 1
Total protein (g/l) 55.65 ± 2.49 52.20 ± 4.65 59.22 ± 3.00 42.00 ± 7.86 4 vs 3
Albumin (g/l) 27.92 ± 0.98 22.88 ± 3.13 26.07 ± 0.65 19.80 ± 3.65 4 vs 1
Globulin (g/l) 27.73 ± 1.63 29.32 ± 2.79 33.15 ± 2.63 22.20 ± 4.30 3 vs 1,2,4; 4 vs 1,2
CRP (mg/dl) 300.00 ± 25.20 306.60 ± 32.90 411.67 ± 55.98 261.71 ± 72.99 3 vs 1,2,4
The number of different P. multocida colony shapes and laboratory results (means ± SD). The last column shows the groups where significant differences were
found. ns: not significant.
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showed that WBC count was lower in group NT than in
group N0, and in groups CT and CE than in group C0.
CRP was lowest in group CE, and also group CT had a
lower CRP than group C0, however, this did not reach
significance. One blood sample in group CE was not suf-
ficient for analysis.Figure 2 Reisolation of P. multocida from infected rats in the
first phase of the animal study. Members of group Ii received
indomethacin treatment and were infected, members of group Mi
received no treatment and were infected.Discussion
In our ex vivo experiments we found that the MPO in-
hibitor indomethacin did not improve the bactericidal
activity of human neutrophil granulocytes. Myeloperoxi-
dase, which has a physiologic role in antibacterial defence,
and antioxidant steroids, like estradiol and hydrocortisone
have a variably positive effect on bactericidal activity. Al-
though the donors were both males and females, we did
not find sex-related differences in the bacterial killing of
PMNs.
The results of our in vivo studies are also in accord-
ance with these. The behaviour of the animals, the death
rates, development of ascites, and most importantly the
reisolation of bacteria all support the negative impact of
indomethacin on the course of the P. multocida infec-
tion. Laboratory findings also show decreased coping
capability of infected and indomethacin treated rats:
higher white blood cell counts, increased neutrophil ra-
tio, anaemia, decreased concentration of serum proteins
(albumin, globulin, total protein) and CRP. Serum pro-
teins, being mediators of the humoral immune system,
give the base of the inflammatory response against mi-
croorganisms. Serum albumin is decreased in inflamma-
tory diseases due to reduced hepatic synthesis [18]. CRP
is an acute phase protein, that can influence multiple stages
of inflammation and has both proinflammatory and antiin-
flammatory effect [19,20]. The collective decrease of these
parameters implies a deteriorated bactericidal capacity. It is
Table 2 Results of the second phase of the animal study
1. N0 2. NT 3. C0 4. CT 5. CE p < 0.05
Castrated No No Yes Yes Yes
Treatment None Testosterone None Testosterone Estradiol
Infection Yes Yes Yes Yes Yes
Colony patterns: Heart blood Liver Heart blood Liver Heart blood Liver Heart blood Liver Heart blood Liver
None 0 2 1 1 1 1 1 1 1 0
1-10 colonies 2 1 4 3 2 1 0 0 4 3
Dense, but separate 2 2 0 2 0 2 1 2 1 3
Confluent 2 1 1 0 2 1 4 3 0 0
Sample number for lab tests 6 6 5 6 5
WBC (×109/l) 10.70 ± 4.18 5.97 ± 3.22 8.26 ± 4.62 3.61 ± 2.14 2.03 ± 1.05 1 vs 4,5
Neutrophil (%) 50.02 ± 21.82 54.30 ± 26.95 54.12 ± 19.20 38.40 ± 26.29 53.15 ± 21.23 ns
Lymphocyte (%) 45.20 ± 22.89 37.46 ± 28.09 39.56 ± 16.32 58.22 ± 23.98 41.15 ± 22.52 ns
RBC (×1012/l) 6.63 ± 0.32 6.44 ± 0.45 5.99 ± 0.47 5.41 ± 0.86 5.95 ± 0.21 4 vs 1,2
HGB (g/dl) 135.40 ± 4.67 132.40 ± 7.16 120.60 ± 12.46 111.40 ± 16.68 120.75 ± 4.65 4 vs 1,2
HCT (l/l) 0.41 ± 0.02 0.40 ± 0.03 0.36 ± 0.03 0.32 ± 0.05 0.35 ± 0.02 4 vs 1,2; 5 vs 1
PLT (×109/l) 718.80 ± 298.45 865.40 ± 212.51 875.60 ± 170.04 696.60 ± 127.91 440.75 ± 198.01 5 vs 2,3
Total protein (g/l) 47.32 ± 2.02 49.53 ± 2.88 51.00 ± 4.45 46.83 ± 4.24 49.76 ± 3.71 ns
Albumin (g/l) 16.68 ± 1.17 17.55 ± 1.18 18.30 ± 1.59 17.03 ± 2.14 18.76 ± 1.50 ns
Globulin (g/l) 30.63 ± 2.67 31.98 ± 2.18 32.70 ± 4.67 29.80 ± 3.03 31.00 ± 2.53 ns
CRP (mg/dl) 375.30 ± 64.54 371.58 ± 33.56 363.30 ± 23.90 329.42 ± 52.21 149.60 ± 131.71 5 vs 1,2,3,4
Testosterone (nmol/l) 21.62 ± 16.08 54.87 ± 1.55 0.87 ± 0.31 41.82 ± 12.10 0.68 ± 0.00 1 vs 2,3,4,5; 2 vs 3,5;
4 vs 3,5
Estradiol (pg/ml) 113.44 ± 30.62 nd 151.75 ± 13.12 nd 867.40 ± 558.15 5 vs 1,3
The number of different P. multocida colony shapes and laboratory results (means ± SD). The last column shows the groups where significant differences were
found. ns: not significant, nd: not determined.
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serum albumin, even without infection. As 90-99% of indo-
methacin is bound to albumin in the bloodstream, reduced
albumin levels lead to an increased concentration of free
indomethacin, and thus an even worse antibacterial activity
during infection [21].
As expected, castration led to weak clinical state, how-
ever, in the untreated groups, castration did not worsen
reisolation and laboratory parameters after infection
with P. multocida. On the other hand, testosterone treat-
ment of castrated animals seems to cause anaemia and
weaker bactericidal capacity when compared to non-
castrated and testosterone-treated rats, but better WBC
and CRP results when compared to the castrated, un-
treated group. Testosterone treatment of non-castrated
animals resulted in stronger bactericidal effect (less rei-
solated bacteria) and lower WBC count after infection
compared to the non-castrated, untreated group. Taken to-
gether, testosterone seems to improve the levels of inflam-
matory parameters compared to the respective control.
The effect of testosterone on the immune system has
been studied by others with various results. It has beenshown that testosterone leads to delayed acquired im-
munity by directly affecting T or B cells [22], reducing
NK cell activity [23], limiting lymphocyte proliferation,
and decreasing immunoglobulin and cytokine produc-
tion [24-26]. Testosterone has been shown to impair
TNF and NO production by macrophages, and to sup-
press NF-κB signal transduction, which has a substantial
role in mediating proinflammatory cytokine production.
It can also enhance the production of anti-inflammatory
cytokines like IL-10 and IL-4 [23]. However, in another
study elevated proinflammatory cytokines such as TNF-α,
IL-6 and IL-1-ß were found in male rats compared to
females [27].
Estradiol treatment of castrated rats seems to enhance
bactericidal defence mechanisms most, as reisolation of
P. multocida showed the lowest colony numbers, and
decreased CRP and WBC count could mean that the in-
fection was less severe due to estradiol pre-treatment. E2
also led to lower platelet count, thus decreasing the risk
of thromboembolism in these animals.
In the literature E2 has been shown to have a dual effect
according to its concentration. Low doses of E2 enhance
Figure 3 Reisolation of P. multocida from infected rats in the second phase of the animal study. a) Members of group N0 received no
treatment besides infection, group NT received testosterone treatment. b) Members of group C0 were castrated, but did not receive treatment
besides infection, members of groups CT and CE were castrated and received either testosterone or estradiol treatment, respectively.
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TNF- α) and T helper cell type 1 (Th1) responses, while
high or sustained E2 concentrations are associated with an
increased susceptibility to infections [28], reduced proin-
flammatory cytokine production and enhanced Th2 re-
sponses and humoral immunity [23,29]. This effect is
thought to be mediated by estrogen receptor signalling,
which suppresses NF-κB activity [30]. E2 can inhibit the
proliferation of mononuclear leukocytes and reduce NK
cell cytotoxicity [26]. In a study with steers, administration
of high doses of E2 did not affect total and differentialWBC count, lymphocyte blastogenesis and neutrophil
function [31]. When given to castrated mice, E2 did not ex-
hibit immunosuppressive effects [22], but another study
concluded that intracellular bacterial killing in PMNs is im-
paired by physiological levels of E2, probably due to a de-
crease in MPO activity [32,33].
According to our previous results, antioxidant steroids
increase MPO activity, which leads to an elevation of the
concentration of hypochlorite, the end product of MPO
induced peroxidation [14-16]. This inhibits the produc-
tion of superoxide anion through a negative feedback
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free radicals derived from superoxide, including hypo-
chlorite [14]. Thus the negative feedback inhibition of
NOX is resolved, and this again results in increased
superoxide generation. Indomethacin treatment, on the
other hand, acts the opposite way [14]. The effect of
MPO and indomethacin in the actual setup probably
depends greatly on the duration of treatment. In the
present setting, the two-hour treatment with indometh-
acin did not cause significant changes, while MPO in-
creased bactericidal activity. The five-day indomethacin
treatment of rats diminished bactericidal activity, prob-
ably by decreasing hypochlorite anion concentration. Ac-
cording to our hypothesis mentioned above, this might
lead to enhanced superoxide anion levels through the in-
hibition of the negative feedback and thus bactericidal
activity would increase as well. However, this potential
regulating mechanism could not reach the level of in-
creased bactericidal activity, because the diminished hypo-
chlorite concentration in the early phase determined the
prognosis of the infection.
Antioxidant steroid hormones seem to improve bac-
tericidal activity in the short run. In the long run, how-
ever, higher hypochlorite levels produced by increased
MPO activity may exhibit negative feedback on NOX,
leading to decreased superoxide generation and bacteri-
cidal activity. Impaired immunity is a known consequence
of chronic steroid overproduction or treatment [34].
It is important to note that our results in the two ex-
perimental models are difficult to compare, one being an
ex vivo, the other an in vivo setup. As detailed above,
sex steroids play a role in a number of innate and ac-
quired immune functions and a variety of immune cell
types have sex steroid receptors [23,24,26,28]. The im-
proved bactericidal activity of PMNs by estradiol con-
firmed by our present experiment is just one of these
effects, and in vivo more complex processes are modu-
lated by sex steroids.
The low number of samples in both the ex vivo and
in vivo experiments is a limitation of our study, so our
findings need further confirmation with greater sample
numbers in the future.
Conclusions
In our experimental models MPO, estradiol, and hydro-
cortisone improve bacterial killing activity of PMNs.
Indomethacin treatment and castration weaken immune
responses and the clinical state of infected rats. These
experiments did not confirm the supposed beneficial ef-
fect of indomethacin in the treatment of septic patients.
On the other hand, testosterone, and even more so es-
tradiol had a beneficial effect in bacterial infection. This
finding needs further confirmation with greater sample
sizes, but based on our results, it is possible, that shortterm adjuvant steroid treatment might have a beneficial
effect in the treatment of bacterial infections and sepsis.
In order to avoid side effects of steroid hormone treat-
ment, it would be reasonable to design an endocrinologi-
cally inactive synthetic compound with the antioxidant
features of the analysed steroids.
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